Brown Advisory Securities, LLC Dexcom Inc Transaction History

Brown Advisory Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$67.99 - $132.89 $31,275 - $61,129	-460 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$94.08 - $130.2 $15,899 - $22,003	-169 Reduced 26.87%	460 $235,000
Q4 2021 Jan 27, 2022	SELL	$129.87 - $162.82 $9,480 - $11,885	-73 Reduced 10.4%	629 $339,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $74,910 - $100,512	702 New	702 $384,000

1,124

353M

4.19M

4.54M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $43.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Brown Advisory Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Securities, LLC with notifications on news.